The Masaya Triple Layer: a 2100 year old basaltic multi-episodic Plinian eruption from the Masaya Caldera Complex (Nicaragua)

The Masaya Caldera Complex has been the site of three highly explosive basaltic eruptions within the last six thousand years. A Plinian eruption ca. 2 ka ago formed the widespread deposits of the Masaya Triple Layer. We distinguish two facies within the Masaya Triple Layer from each other: La Concepción facies to the south and Managua facies to the northwest. These two facies were previously treated as two separated deposits (La Concepción Tephra and the Masaya Triple Layer of Pérez and Freundt, 2006) because of their distinct regional distribution and internal architectures. However, chemical compositions of bulk rock, matrix and inclusion glasses and mineral phases demonstrate that they are the product of a single basaltic magma batch. Additionally, a marker bed containing fluidal-shaped vesicular lapilli allowed us to make a plausible correlation between the two facies, also supported by consistent lateral changes in lithologic structure and composition, thickness and grain size. We distinguish 10 main subunits of the Masaya Triple Layer (I to X), with bulk volumes ranging between 0.02 and 0.22 km3, adding up to 0.86 km3 (0.4 km3 DRE) for the entire deposit. Distal deposits identified in two cores drilled offshore Nicaragua, at a distance of ∼ 170 km from the Masaya Caldera Complex, increase the total tephra volume to 3.4 km3 or ∼ 1.8 km3 DRE of erupted basaltic magma. Isopleth data of five major fallout subunits indicate mass discharges of 106 to 108 kg/s and eruption columns of 21 to 32 km height, affected by wind speeds of < 2 m/s to ∼ 20 m/s which increased during the course of the multi-episodic eruption. Magmatic Plinian events alternated with phreatoplinian eruptions and phreatomagmatic explosions generating surges that typically preceded breaks in activity. While single eruptive episodes lasted for few hours, the entire eruption probable lasted weeks to months. This is indicated by changes in atmospheric conditions and ash-layer surfaces that had become modified during the breaks in activity. The Masaya Triple Layer has allowed to reconstruct in detail how a basaltic Plinian eruption develops in terms of duration, episodicity, and variable access of external water to the conduit, with implications for volcanic hazard assessment

Management of patients with biliary sphincter of Oddi disorder without sphincter of Oddi manometry

<p>Abstract</p> <p>Background</p> <p>The paucity of controlled data for the treatment of most biliary sphincter of Oddi disorder (SOD) types and the incomplete response to therapy seen in clinical practice and several trials has generated controversy as to the best course of management of these patients. In this observational study we aimed to assess the outcome of patients with biliary SOD managed without sphincter of Oddi manometry.</p> <p>Methods</p> <p>Fifty-nine patients with biliary SOD (14% type I, 51% type II, 35% type III) were prospectively enrolled. All patients with a dilated common bile duct were offered endoscopic retrograde cholangiopancreatography (ERCP) and sphincterotomy whereas all others were offered medical treatment alone. Patients were followed up for a median of 15 months and were assessed clinically for response to treatment.</p> <p>Results</p> <p>At follow-up 15.3% of patients reported complete symptom resolution, 59.3% improvement, 22% unchanged symptoms, and 3.4% deterioration. Fifty-one percent experienced symptom resolution/improvement on medical treatment only, 12% after sphincterotomy, and 10% after both medical treatment/sphincterotomy. Twenty percent experienced at least one recurrence of symptoms after initial response to medical and/or endoscopic treatment. Fifty ERCP procedures were performed in 24 patients with an 18% complication rate (16% post-ERCP pancreatitis). The majority of complications occurred in the first ERCP these patients had. Most complications were mild and treated conservatively. Age, gender, comorbidity, SOD type, dilated common bile duct, presence of intact gallbladder, or opiate use were not related to the effect of treatment at the end of follow-up (p > 0.05 for all).</p> <p>Conclusions</p> <p>Patients with biliary SOD may be managed with a combination of endoscopic sphincterotomy (performed in those with dilated common bile duct) and medical therapy without manometry. The results of this approach with regards to symptomatic relief and ERCP complication rate are comparable to those previously published in the literature in cohorts of patients assessed by manometry.</p

Pacific offshore record of plinian arc volcanism in Central America: 1. Along-arc correlations

We collected 56 marine gravity cores from the Pacific seafloor offshore Central America which contain a total of 213 volcanic ash beds. Ash-layer correlations between cores and with their parental tephras on land use stratigraphic, lithologic, and compositional criteria. In particular, we make use of our newly built database of bulk-rock, mineral, and glass major and trace element compositions of plinian and similarly widespread tephras erupted since the Pleistocene along the Central American Volcanic Arc. We thus identify the distal ashes of 11 Nicaraguan, 8 El Salvadorian, 6 Guatemalan, and 1 Costa Rican eruptions. Relatively uniform pelagic sedimentation rates allow us to determine ages of 10 previously undated tephras by their relative position between ash layers of known age. Linking the marine and terrestrial records yields a tephrostratigraphic framework for the Central American volcanic arc from Costa Rica to Guatemala. This is a useful tool and prerequisite to understand the evolution of volcanism at a whole-arc scale

Mineralogical and geochemical analysis of Fe-phases in drill-cores from the Triassic Stuttgart Formation at Ketzin CO₂ storage site before CO₂ arrival

Reactive iron (Fe) oxides and sheet silicate-bound Fe in reservoir rocks may affect the subsurface storage of CO2 through several processes by changing the capacity to buffer the acidification by CO2 and the permeability of the reservoir rock: (1) the reduction of three-valent Fe in anoxic environments can lead to an increase in pH, (2) under sulphidic conditions, Fe may drive sulphur cycling and lead to the formation of pyrite, and (3) the leaching of Fe from sheet silicates may affect silicate diagenesis. In order to evaluate the importance of Fe-reduction on the CO2 reservoir, we analysed the Fe geochemistry in drill-cores from the Triassic Stuttgart Formation (Schilfsandstein) recovered from the monitoring well at the CO2 test injection site near Ketzin, Germany. The reservoir rock is a porous, poorly to moderately cohesive fluvial sandstone containing up to 2–4 wt% reactive Fe. Based on a sequential extraction, most Fe falls into the dithionite-extractable Fe-fraction and Fe bound to sheet silicates, whereby some Fe in the dithionite-extractable Fe-fraction may have been leached from illite and smectite. Illite and smectite were detected in core samples by X-ray diffraction and confirmed as the main Fe-containing mineral phases by X-ray absorption spectroscopy. Chlorite is also present, but likely does not contribute much to the high amount of Fe in the silicate-bound fraction. The organic carbon content of the reservoir rock is extremely low (<0.3 wt%), thus likely limiting microbial Fe-reduction or sulphate reduction despite relatively high concentrations of reactive Fe-mineral phases in the reservoir rock and sulphate in the reservoir fluid. Both processes could, however, be fuelled by organic matter that is mobilized by the flow of supercritical CO2 or introduced with the drilling fluid. Over long time periods, a potential way of liberating additional reactive Fe could occur through weathering of silicates due to acidification by CO2

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

Peptide receptor radionuclide therapy (PRRNT) is a molecularly targeted radiation therapy involving the systemic administration of a radiolabelled peptide designed to target with high affinity and specificity receptors overexpressed on tumours. PRRNT employing the radiotagged somatostatin receptor agonists (90)Y-DOTATOC ([(90)Y-DOTA(0),Tyr(3)]-octreotide) or (177)Lu-DOTATATE ([(177)Lu-DOTA(0),Tyr(3),Thr(8)]-octreotide or [(177)Lu-DOTA(0),Tyr(3)]-octreotate) have been successfully used for the past 15 years to target metastatic or inoperable neuroendocrine tumours expressing the somatostatin receptor subtype 2. Accumulated evidence from clinical experience indicates that these tumours can be subjected to a high absorbed dose which leads to partial or complete objective responses in up to 30 % of treated patients. Survival analyses indicate that patients presenting with high tumour receptor expression at study entry and receiving (177)Lu-DOTATATE or (90)Y-DOTATOC treatment show significantly higher objective responses, leading to longer survival and improved quality of life. Side effects of PRRNT are typically seen in the kidneys and bone marrow. These, however, are usually mild provided adequate protective measures are undertaken. Despite the large body of evidence regarding efficacy and clinical safety, PRRNT is still considered an investigational treatment and its implementation must comply with national legislation, and ethical guidelines concerning human therapeutic investigations. This guidance was formulated based on recent literature and leading experts’ opinions. It covers the rationale, indications and contraindications for PRRNT, assessment of treatment response and patient follow-up. This document is aimed at guiding nuclear medicine specialists in selecting likely candidates to receive PRRNT and to deliver the treatment in a safe and effective manner. This document is largely based on the book published through a joint international effort under the auspices of the Nuclear Medicine Section of the International Atomic Energy Agency